Signor Luca, Varesio Emmanuel, Staack Roland F, Starke Volkmar, Richter Wolfgang F, Hopfgartner Gérard
University of Geneva, University of Lausanne, School of Pharmaceutical Sciences, Life Sciences Mass Spectrometry, 20 Boulevard d'Yvoy, CH-1211 Geneva 4, Switzerland.
J Mass Spectrom. 2007 Jul;42(7):900-9. doi: 10.1002/jms.1225.
A qualitative and quantitative analysis of erlotinib (RO0508231) and its metabolites was carried out on rat tissue sections from liver, spleen and muscle. Following oral administration at a dose of 5 mg/kg, samples were analyzed by matrix-assisted laser desorption ionization (MALDI) with mass spectrometry (MS) using an orthogonal quadrupole time-of-flight instrument. The parent compound was detected in all tissues analyzed. The metabolites following drug O-dealkylation could also be detected in liver sections. Sinapinic acid (SA) matrix combined with the dried-droplet method resulted in better conditions for our analysis on tissues. Drug quantitation was investigated by the standard addition method and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis on the tissue extracts. The presence of the parent compound and of its O-demethylated metabolites was confirmed in all tissue types and their absolute amounts calculated. In liver the intact drug was found to be 3.76 ng/mg tissue, while in spleen and muscle 6- and 30-fold lower values, respectively, were estimated. These results were compared with drug quantitation obtained by whole-body autoradiography, which was found to be similar. The potential for direct quantitation on tissue sections in the presence of an internal standard was also investigated using MALDI-MS. The use of alpha-cyano-4-hydroxycinnamic acid (CHCA) as the matrix resulted in better linearity for the calibration curves obtained with reference solutions of the drug when compared to SA, but on tissue samples no reliable quantitative analysis was possible owing to the large variability in the signal response. MS imaging experiments using MALDI in MS/MS mode allowed visualizing the distribution of the parent compound in liver and spleen tissues. By calculating the ratio between the total ion intensities of MS images for liver and spleen sections, a value of 6 : 1 was found, which is in good agreement with the quantitative data obtained by LC-MS/MS analysis.
对来自大鼠肝脏、脾脏和肌肉的组织切片进行了厄洛替尼(RO0508231)及其代谢物的定性和定量分析。以5 mg/kg的剂量口服给药后,使用正交四极杆飞行时间仪器通过基质辅助激光解吸电离(MALDI)和质谱(MS)对样品进行分析。在所有分析的组织中均检测到母体化合物。在肝脏切片中也可检测到药物O-去烷基化后的代谢物。芥子酸(SA)基质与干滴法相结合为我们对组织的分析提供了更好的条件。通过标准加入法和对组织提取物的液相色谱-串联质谱(LC-MS/MS)分析对药物进行定量研究。在所有组织类型中均确认了母体化合物及其O-去甲基化代谢物的存在,并计算了它们的绝对量。在肝脏中,完整药物的含量为3.76 ng/mg组织,而在脾脏和肌肉中分别估计为其6倍和30倍低的值。将这些结果与通过全身放射自显影获得的药物定量结果进行比较,发现两者相似。还使用MALDI-MS研究了在存在内标物的情况下对组织切片进行直接定量的可能性。与SA相比,使用α-氰基-4-羟基肉桂酸(CHCA)作为基质时,药物参考溶液获得的校准曲线具有更好的线性,但由于信号响应的巨大变异性,在组织样品上无法进行可靠的定量分析。使用MALDI在MS/MS模式下进行的MS成像实验可以可视化母体化合物在肝脏和脾脏组织中的分布。通过计算肝脏和脾脏切片的MS图像的总离子强度之比,发现为6:1,这与通过LC-MS/MS分析获得的定量数据高度一致。